trending Market Intelligence /marketintelligence/en/news-insights/trending/fjxelopcoegzdctmem5ahq2 content esgSubNav
In This List

Imugene appoints managing director

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Imugene appoints managing director

Imugene Ltd. appointed Leslie Chong as its managing director.

Chong is the CEO of the Australian biopharmaceutical company, and her remuneration remains unchanged after the appointment.

Imugene is developing a vaccine for the treatment of gastric cancer.